Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Poels

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Anticancer Research|November 1, 1991
Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic miceL F Massuger, O C Boerman, F H Corstens, et al.
Biochimica Et Biophysica Acta|April 12, 1995
Design of immunoliposomes directed against human ovarian carcinomaU K Nässander, P A Steerenberg, W H De Jong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1990
Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibodyL F Massuger, P Kenemans, R A Claessens, et al.
Journal of the National Cancer Institute|May 1, 1986
Monoclonal antibody against human ovarian tumor-associated antigensL G Poels, D Peters, Y van Megen, et al.
International Journal of Cancer|May 15, 1990
Cell lines of human oral squamous-cell carcinomas retaining their differentiated phenotypeR P Crooijmans, J H Schwachöfer, J Hoogenhout, et al.
Nature|June 12, 1980
Is actin in eye lens a possible factor in visual accomodation?M A Kibbelaar, F C Ramaekers, P J Ringens, et al.
International Journal of Cancer|June 15, 1989
ETN-1: a new human endometrial carcinoma cell line producing ascites and distant metastases in nude miceR F Kruitwagen, L G Poels, W N Willemsen, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-GuérinP A Steerenberg, W H De Jong, E Geerse, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Anticancer Research|November 1, 1991
Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic miceL F Massuger, O C Boerman, F H Corstens, et al.
Biochimica Et Biophysica Acta|April 12, 1995
Design of immunoliposomes directed against human ovarian carcinomaU K Nässander, P A Steerenberg, W H De Jong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1990
Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibodyL F Massuger, P Kenemans, R A Claessens, et al.
Journal of the National Cancer Institute|May 1, 1986
Monoclonal antibody against human ovarian tumor-associated antigensL G Poels, D Peters, Y van Megen, et al.
International Journal of Cancer|May 15, 1990
Cell lines of human oral squamous-cell carcinomas retaining their differentiated phenotypeR P Crooijmans, J H Schwachöfer, J Hoogenhout, et al.
Nature|June 12, 1980
Is actin in eye lens a possible factor in visual accomodation?M A Kibbelaar, F C Ramaekers, P J Ringens, et al.
International Journal of Cancer|June 15, 1989
ETN-1: a new human endometrial carcinoma cell line producing ascites and distant metastases in nude miceR F Kruitwagen, L G Poels, W N Willemsen, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-GuérinP A Steerenberg, W H De Jong, E Geerse, et al.
Pageof 6